Overview of Dr. Ballinger
Dr. Tarah Ballinger is an oncologist in Indianapolis, IN and is affiliated with Indiana University Health University Hospital. She received her medical degree from Indiana University School of Medicine and has been in practice 7 years. She is one of 96 doctors at Indiana University Health University Hospital who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
1030 W Michigan St
Indianapolis, IN 46202Fax+1 317-278-2262
Education & Training
Vanderbilt University Medical CenterResidency, Internal Medicine, 2012 - 2015
Indiana University School of MedicineClass of 2012
Certifications & Licensure
IN State Medical License 2015 - 2025
TN State Medical License 2014 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Effects of Aromatase Inhibitor Therapy on Muscle Function Start of enrollment: 2018 Jul 26
- Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors Start of enrollment: 2019 Oct 02
- Assessing Exercise Behavior and Preferences Among Patients and Oncologists Start of enrollment: 2019 Apr 08
- Join now to see all
Publications & Presentations
PubMed
- Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer.Catherine E Mosher, Shieun Lee, Elizabeth L Addington, Seho Park, Ashley B Lewson
Journal of Clinical Oncology. 2025-02-20 - Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence.Jennifer W Bea, Heather M Ochs-Balcom, Celina I Valencia, Zhao Chen, Robert M Blew
JNCI Cancer Spectrum. 2025-01-03 - Improving communication to increase uptake of high-risk breast cancer prevention appointments: Building a better letter.Evan K Perrault, Maria K Venetis, Tarah J Ballinger
PEC Innovation. 2024-12-15
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
IU Research Targets Debilitating Side Effects for Black Breast Cancer PatientsSeptember 9th, 2024- Q & a: How Does Exercise Benefit Cancer Patients?March 13th, 2024
- She Served in Afghanistan and Kuwait and Is Now Fighting Breast CancerOctober 27th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
